Welcome to LookChem.com Sign In|Join Free
  • or
4-(2-methoxycarbonyl-phenylsulfanyl)-3-nitro-benzoic acid ethyl ester is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

917237-08-2

Post Buying Request

917237-08-2 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

917237-08-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 917237-08-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,1,7,2,3 and 7 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 917237-08:
(8*9)+(7*1)+(6*7)+(5*2)+(4*3)+(3*7)+(2*0)+(1*8)=172
172 % 10 = 2
So 917237-08-2 is a valid CAS Registry Number.

917237-08-2Relevant academic research and scientific papers

MUSCARINIC AGONISTS

-

Page/Page column 26-27, (2010/06/17)

Compounds of the general formula (I) and methods are provided for the treatment of disease conditions in which the modification of cholinergic, especially muscarinic receptor activity, has a beneficial effect. In the method, an effective amount of a compo

Synthesis and evaluation of dibenzothiazepines: A novel class of selective cannabinoid-1 receptor inverse agonists

Pettersson, Hanna,Bülow, Anne,Ek, Fredrik,Jensen, Jacob,Ottesen, Lars K.,Fejzic, Alma,Ma, Jian-Nong,Tredici, Andria L. Del,Currier, Erika A.,Gardell, Luis R.,Tabatabaei, Ali,Craig, Darren,McFarland, Krista,Ott, Thomas R.,Piu, Fabrice,Burstein, Ethan S.,Olsson, Roger

supporting information; experimental part, p. 1975 - 1982 (2009/12/31)

A novel class of CB1 inverse agonists was discovered. To efficiently establish structure-activity relationships (SARs), new synthetic methodologies amenable for parallel synthesis were developed. The compounds were evaluated in a mammalian cell-based func

USE OF CANNABINOID MODULATING COMPOUNDS IN COMBINATION WITH OTHER THERAPEUTIC COMPOUNDS FOR ADJUNCTIVE THERAPY

-

Page/Page column 83-84, (2008/12/04)

The present invention relates to pharmaceutical compositions that contain a compound that modulate the activity of a cannabinoid receptor in conjunction with another therapeutic compound and uses of compounds that modulate the activity of a cannabinoid re

CB-1 MODULATING COMPOUNDS AND THEIR USE

-

Page/Page column 53-54, (2008/06/13)

Disclosed herein is a compound of Formula (I). Also disclosed herein is a method of modulating the activity of a cannabinoid receptor using a compound of Formula (I). Furthermore, disclosed herein is a method of treating a disease or condition that would

IRON CATALYZED CROSS-COUPLING REACTIONS OF IMIDOYL DERIVATIVES

-

Page/Page column 37; 53, (2010/11/27)

Disclosed is a process for preparing a compound of formula A - N=C(D)(B), from a compound of formula A-N=C(E)(B) and a compound of formula D-M using an iron catalyst, where the process has is represented by Equation (I).

Iron-catalyzed cross-coupling of imidoyl chlorides with Grignard reagents

Ottesen, Lars K.,Ek, Fredrik,Olsson, Roger

, p. 1771 - 1773 (2007/10/03)

A general, high yielding rapid iron-catalyzed cross-coupling reaction between Grignard reagents and imidoyl chlorides is described. These reactions are typically completed within 5 min, resulting in high yields of 71-96% using 5% iron catalyst in a THF-NM

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 917237-08-2